New research released in April’s American Journal of Public Health discovered anti-tobacco advertising does help reduce the need to spark up in adults, however only when the ads are from sponsors not associated with the tobacco industry. In states where anti-tobacco ads were sponsored by private initiatives, pharmaceutical and the state itself, the anti smoking message had greater impact. Ads created or sponsored directly by the tobacco industry prompted more smoking in states which ran these campaigns. However, although the anti-smoking ads delivered by pharmaceutical companies were more effective in getting people to smoke less, running ads for cessation products appear to have turned people off potentially quitting their addiction.
New research released this week by the University of Buffalo suggests smokers might have more success at kicking the habit if they start using smoking cessation medications, such as varenicline, for several weeks prior to their quit date. Findings showed that smokers who took the medication for four weeks prior to quitting were more likely to remain tobacco-free three months after the trail ended, compared to those who only took the drug for the regularly prescribed time frame of one week. The female participants also fared better in their quest to quit, with 67% remaining smoke free at the three month follow up.
New research from the Tobacco Dependence Clinic at the Dentistry of New Jersey’s School of Public Health has gone to show why quitting smoking this resolution season might be harder for some smokers than others.